Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Arcus Biosciences

Biotech & Life Sciences · Hayward, United States · Founded 2015 · IPO 2018 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$2.16B
Market cap · Apr/2026
Revenue
$247M
Latest reported FY

Investors

12 investors on Arcus Biosciences's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage
Celgene
The Column Group
Series B+ 10 investors entered at this stage
Foresite Capital
Taiho Pharma
GV
Novartis
Decheng Capital
Wellington Management
Aisling Capital
Invus
RTA Capital
EcoR1 Capital

Global footprint

Where Arcus Biosciences has talent and traffic

AI talent share
0.3% of workforce is AI talent
(2 of 655 staff)
Core AI00%
Other AI20.31%
Non-AI workforce65399.69%
Web traffic by country
14K monthly visits
across markets
🇺🇸 United States65%
🇮🇳 India13.6%
🇬🇧 United Kingdom10.7%
🇨🇦 Canada4.3%
🇯🇵 Japan2.9%
Top 5 markets shown

Patent intelligence

$74M patent portfolio · 68 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$74M
3.4% of market cap · 7.1× smaller than top peer ChemoCentryx ($524M)
68 active patent families
Where Arcus Biosciences innovates DiseaseCarcinosisMolecular biologyPharmacologyCancer research
Below peer median on Legal, Strategic, Market

Quality vs same-sector peers

Arcus Biosciences on the five Patsnap quality dimensions

Arcus Biosciences in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Arcus Biosciences concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Arcus Biosciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Arcus Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo